HighTower Advisors LLC decreased its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 4.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 816,732 shares of the company's stock after selling 33,957 shares during the quarter. HighTower Advisors LLC owned 0.10% of Colgate-Palmolive worth $64,538,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Colgate-Palmolive by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company's stock worth $6,633,570,000 after buying an additional 1,026,985 shares in the last quarter. Invesco Ltd. increased its holdings in Colgate-Palmolive by 13.1% in the 3rd quarter. Invesco Ltd. now owns 8,467,993 shares of the company's stock worth $676,931,000 after buying an additional 978,943 shares in the last quarter. Diamond Hill Capital Management Inc. increased its holdings in Colgate-Palmolive by 46.7% in the 3rd quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company's stock worth $645,719,000 after buying an additional 2,572,796 shares in the last quarter. First Eagle Investment Management LLC increased its holdings in Colgate-Palmolive by 0.4% in the 4th quarter. First Eagle Investment Management LLC now owns 7,918,979 shares of the company's stock worth $625,758,000 after buying an additional 29,876 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its holdings in Colgate-Palmolive by 5.1% in the 3rd quarter. Ameriprise Financial Inc. now owns 6,423,764 shares of the company's stock worth $517,167,000 after buying an additional 314,584 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on the company. Jefferies Financial Group lifted their price objective on Colgate-Palmolive from $85.00 to $91.00 and gave the stock a "hold" rating in a report on Monday, February 2nd. Morgan Stanley reiterated an "overweight" rating on shares of Colgate-Palmolive in a research note on Monday, May 4th. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the company an "overweight" rating in a research note on Monday, May 4th. The Goldman Sachs Group reiterated a "buy" rating on shares of Colgate-Palmolive in a research note on Friday, May 1st. Finally, Barclays boosted their target price on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the company an "equal weight" rating in a research note on Tuesday, May 5th. Twelve analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $95.88.
Check Out Our Latest Stock Report on CL
Colgate-Palmolive Price Performance
Shares of NYSE:CL opened at $90.44 on Thursday. The firm's 50 day moving average price is $86.12 and its 200-day moving average price is $85.02. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. The stock has a market capitalization of $72.56 billion, a PE ratio of 35.19, a price-to-earnings-growth ratio of 4.67 and a beta of 0.31.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.03. The firm had revenue of $5.32 billion for the quarter, compared to analysts' expectations of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business's quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 EPS. Equities research analysts expect that Colgate-Palmolive Company will post 3.82 EPS for the current year.
Colgate-Palmolive Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, April 20th were given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.3%. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.52. The ex-dividend date was Monday, April 20th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 82.49%.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Featured Stories
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.